| 注册
首页|期刊导航|临床误诊误治|银杏活性成分在恶性肿瘤治疗中的机制研究及进展

银杏活性成分在恶性肿瘤治疗中的机制研究及进展

王晓锋 廖彩红 李嘉 曾志威 熊天增

临床误诊误治2026,Vol.39Issue(2):106-110,5.
临床误诊误治2026,Vol.39Issue(2):106-110,5.DOI:10.3969/j.issn.1002-3429.2026.02.016

银杏活性成分在恶性肿瘤治疗中的机制研究及进展

Mechanism and research progress of ginkgo active ingredients in the treatment of malignant tumors

王晓锋 1廖彩红 2李嘉 1曾志威 3熊天增4

作者信息

  • 1. 梅州市人民医院(梅州市医学科学院)耳鼻咽喉二科,广东梅州 514031
  • 2. 兴宁市永和镇卫生院药房,广东兴宁 514500
  • 3. 梅州市人民医院(梅州市医学科学院)中医科,广东梅州 514031
  • 4. 梅州市人民医院(梅州市医学科学院)药剂科,广东梅州 514031
  • 折叠

摘要

Abstract

Ginkgo biloba has various active ingredients,primarily including flavonoid glycosides,terpene lactones,and ginkgolic acids.The extracts of Ginkgo biloba have various pharmacological effects such as antioxidant,anti-aging,antidepressant,antibacterial,antiviral and anti-tumor activities.Malignant tumors are related to numerous factors such as environment,living habits,chronic inflammation and genetic susceptibility.At present,the treatment of malignant tumors is still a challenge to be overcome in clinical practice.The optimization of relevant diagnosis and treatment strategies and individualized treatment programs are the focus of medical attention.This article describes the pharmacological effects and application prospects of active ingredients of Ginkgo biloba,and analyzes its potential mechanism of efficacy in the treatment of malignant tumors,so as to provide ideas for clinical optimization of malignant tumor treatment programs and exploration of feasible adjuvant treatment methods.

关键词

银杏/活性成分/恶性肿瘤/黄酮类苷/萜内酯/银杏酸/综述

Key words

Ginkgo biloba/active ingredients/malignant tumor/flavonoid glycosides/terpene lactone/ginkgolic acid/review

引用本文复制引用

王晓锋,廖彩红,李嘉,曾志威,熊天增..银杏活性成分在恶性肿瘤治疗中的机制研究及进展[J].临床误诊误治,2026,39(2):106-110,5.

基金项目

广东省中医药局科研项目(20262060) (20262060)

临床误诊误治

1002-3429

访问量1
|
下载量0
段落导航相关论文